ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 Nov 2024 15:30:00 By Nasdaq GlobeNewswire

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit

09 Nov 2024 09:30:00 By Nasdaq GlobeNewswire

Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update

05 Nov 2024 15:01:00 By Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Third Quarter 2024 Financial Results and Corporate Update

29 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 Oct 2024 15:30:00 By Nasdaq GlobeNewswire

Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta

07 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease

03 Oct 2024 15:30:00 By Nasdaq GlobeNewswire

Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting

26 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 Sep 2024 16:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

16 Sep 2024 11:51:10 By NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

13 Sep 2024 09:04:25 By NetDania Notify

Ultragenyx to Participate in Investor Conferences in September

29 Aug 2024 15:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

29 Aug 2024 09:17:24 By NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

28 Aug 2024 09:40:17 By NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

26 Aug 2024 11:35:19 By NetDania Notify

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

22 Aug 2024 08:45:08 By NetDania Notify

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 Aug 2024 15:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

21 Aug 2024 09:00:12 By NetDania Notify

Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update

01 Aug 2024 15:05:39 By Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update

25 Jul 2024 15:05:00 By Nasdaq GlobeNewswire